Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Fisher Scientific Launches Maybridge Ro3 Diversity Fragment Library

Published: Tuesday, July 06, 2010
Last Updated: Thursday, July 15, 2010
Bookmark and Share
Diverse set of 1,500 molecules engineered for high-quality fragment screening-based programmes.

Thermo Fisher Scientific has introduced the latest addition to its Maybridge Fragment Range, the Maybridge Ro3 Diversity Fragment Library.

According to Thermo Fisher, the new library has been computationally engineered to build on the key customer-driven features of the original Maybridge Ro3 Library, such as “Rule of Three” (Ro3) compliance, pharmacophoric enrichment and quality assurance of at least 95 percent. The Maybridge Ro3 Diversity Library can offer both an improved structural diversity profile and experimental solubility data for every one of the 1,500 member compounds.

Full Ro3 compliance means that all 1,500 fragments have the physicochemical properties that increase the probability of successful hits. The broad portfolio also provides access to analogues for fragment hopping, as well as reactive analogues for rapid hit evolution and derivatisation. Consequently, these Maybridge Fragments provide an ideal starting point for a lead-optimization, structure-based drug discovery programme and the ultimate evolution of a new molecule in the drug discovery process.

Every fragment in the new Maybridge library has been experimentally triaged to assure solubility in both DMSO (200mM) and aqueous phosphate buffer (1mM). Aqueous solubility is a prerequisite for successful in vitro testing, as poor solubility can compromise the robustness of the screening data through aggregation and promiscuous inhibition. Fragment hits with poor aqueous solubility are also more likely to produce evolved analogues with inferior ADME properties, such as plasma protein binding, poor systemic distribution and an increased likelihood of candidate attrition. The Maybridge Ro3 Diversity Fragment Library mitigates all such issues.

When building the new Maybridge library, Maybridge scientists applied Daylight-based structural fingerprinting techniques (1024 bit length) to an Ro3 compliant set of 8,000 fragments and the fingerprinted set then clustered using industry standard clustering software (DBClus)1. The resulting representative set of 1,500 high-quality molecules consists of 819 cluster centroids and 690 singletons at a Tanimoto level of 0.66.

“As the field of fragment–based drug discovery continues to mature there is an increasing need to gain access to fragments of the highest quality,” said Simon Pearce, Maybridge product manager. “Built on a pedigree of almost 50 years of heterocycle research, our Maybridge Fragment Range has grown with the technology over the past six years, as structure-based techniques such as NMR become more central to the drug discovery process. In fact, many successful fragment screening programmes have Maybridge Fragments at their heart.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Q3 Revenues up 31 Percent
Thermo Fisher announced that revenues grew 31% to $4.17 billion for the third quarter ended September 27, 2014.
Thursday, October 23, 2014
Thermo, Nuclea Biotechnologies Collaborate to Develop Diabetes Markers
Companies pooling their expertise to develop novel multiplexed research methods for high-throughput quantification of native insulin and its therapeutic analogs.
Monday, June 02, 2014
Thermo Reports 22% Revenue Rise in Q1 2014
Results include the addition of Life Technologies as of February 4, 2014, and exclude the previously announced related divestitures as of March 22, 2014.
Wednesday, April 23, 2014
Thermo Reports 6% Q4 Revenue Growth
Thermo Fisher Scientific Inc. reported its financial results for the fourth quarter and full year ended December 31, 2013.
Friday, January 31, 2014
Thermo Scientific Forms Technology Alliance Partnership With University of Birmingham
Collaboration aimed at advancing LC-MS techniques in life science research.
Friday, March 29, 2013
Record Revenues for Thermo Fisher Scientific
Revenue for the quarter grew 6% to $3.26 billion in 2012, versus $3.09 billion in 2011.
Thursday, January 31, 2013
Thermo Fisher Scientific and NUS Form Collaboration
Goal to develop mass spectrometry-based techniques to study metabolites.
Monday, January 28, 2013
Thermo Fisher Scientific and Intrinsic Bioprobes Collaborate to Develop MS Immunoassay Workflow
Turnkey MSIA solution allows researchers to differentiate and quantitate low-abundance intact proteins and their variants.
Friday, July 16, 2010
Thermo Fisher Scientific Collaborates with Leading Proteomics Researcher in Luxembourg
Collaboration aims to develop workflows to overcome current bottlenecks in biomarker discovery and assay development for clinical proteomics research.
Monday, April 26, 2010
Thermo Fisher Scientific, GMU, Johns Hopkins and Toronto’s UHN Extend Collaboration
Accelerating biomarker identification for cancer and other diseases may speed development of diagnostic tests that enable earlier disease detection.
Wednesday, March 31, 2010
Thermo Fisher Scientific Collaborates with Expression Pathology
The collaboration will apply both companies’ expertise for identification of cancer-related proteins.
Friday, December 18, 2009
Thermo Fisher Scientific Names Recipients of RNAi Discovery Grants
More than $400,000 in RNAi screening tools awarded to advance biomedical research and drug discovery.
Friday, November 06, 2009
Thermo Fisher Scientific and Symyx Technologies to Deliver Integrated LIMS and ELN Solutions to Scientists
Thermo Fisher Scientific Inc., today announced the release of a joint product development effort resulting from its partnership with Symyx Technologies.
Tuesday, October 27, 2009
Thermo Fisher Scientific Introduces Linear Ion Trap Trade-Up Program for Single Quadrupole and Ion Trap LC-MS Users
Thermo Fisher Scientific Inc. today announced the introduction of a new program that invites scientists to trade in their single quadrupole or ion trap mass spectrometer - from any vendor - and upgrade to leading Thermo Scientific linear ion trap technology
Wednesday, October 07, 2009
Thermo Fisher Scientific Signs Agreement to Acquire B.R.A.H.M.S. AG
Company acquires provider of specialty in-vitro diagnostic tests for $470 million USD.
Monday, September 07, 2009
Scientific News
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?
An MD Anderson study has shown the potential of a simple molecule involved in cancer metabolism as a powerful therapeutic.
Study Reveals Improved Way to Interpret High-Throughput Biological Data
A recent study has revealed a novel workflow, identifying associations between molecules to provide insights into cellular metabolism and gene expression in complex biological systems.
Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.
Researchers Link Liver Disease and Drug Metabolism
Researchers have discovered that nonalcoholic steatohepatitis, an increasingly common but often undiagnosed liver disease, could have significant medical implications for people with type 2 diabetes.
Scientists Create Synthetic Membranes That Grow Like Living Cells
Chemists and biologists at UC San Diego have succeeded in designing and synthesizing an artificial cell membrane capable of sustaining continual growth, just like a living cell.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Team Led by TSRI Scientists Shows AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
New research shows that an experimental vaccine candidate can stimulate immune activity necessary to prevent HIV infection.
The Perfect Partnership: Research & Industry; Software & Instrumentation. It really starts to come together at ASMS 2015
Collaboration and knowledge-sharing were evident everywhere: on the bus, in the hallways and in the bars. This article aims to capture this theme and share with you some of the fruits of this coming together of science and industry.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!